Skip to headlines
clockwire Search
LIVE
Fastenal, Grainger cut at Baird, as outlook for industrial distributors turns negative Austin Democrats vie for Texas Senate seat Thanksgiving travel rush to test Chicago airports after FAA disruptions Former WBEZ host Sasha-Ann Simons joins D.C. mayor-elect's team Scoop: Witkoff and Kushner meet Qatari mediators to discuss Iran negotiations Miami Art Week, Art Basel feature lineup of concerts Johnson urges Republicans to show up to work Dial 1-800-Butterball for more than just turkey tips Second judge blocks Trump's contested D.C. arch "GTA VI" players spot Sunshine Skyway Bridge, Lakeland's Lake Mirror Union Pacific CEO apologizes after merger opponents pounce on rate hike warning David Chang gives Pittsburgh the tourist treatment Young artists light up Austin's Zilker holiday tree Americans feel better about their pocketbooks this month Sila's 15-year battery bet pays off with Panasonic deal
‹ Back to your news
This $8 pharma stock is up 52%—and still trades at 1.6x earnings

MARKETS United States

This $8 pharma stock is up 52%—and still trades at 1.6x earnings

Covered by 2 sources · 1 wire story + 0 independent reports Earliest report we found · latest report

How each outlet tells it

Wire story · carried by Investing.com, Yahoo Finance

This $8 pharma stock is up 52%—and still trades at 1.6x earnings

This $8 pharma stock is up 52%—and still trades at 1.6x earnings

Carried by 2 outlets in 2 countries

  1. Investing.com (GB) ·
  2. Yahoo Finance (US) ·